The role of necroptosis in neurosurgical diseases

Brazilian Journal of Medical and Biological Research

Volumn 48, Issue 4, 2015, Pages 292-298

  Liu, T ^a   Bao, Ying Hui ^a   Wang, Y ^a   Jiang, J Y ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Molecular mechanism; Pathogenesis; Programmed cell death; Therapy

Indexed keywords

24 HYDROXYCHOLESTEROL; ACYL COENZYME A; ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE TRIPHOSPHATE; APOPTOSIS INDUCING FACTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CASPASE 8; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL DERIVATIVE; CYCLOPHILIN D; CYTOSOLIC PHOSPHOLIPASE A2; DEATH RECEPTOR 4; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; NECROSTATIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN KINASE B; PROTEINASE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR; NEUROPROTECTIVE AGENT;

APOPTOSIS; BRAIN TUMOR; CEREBROVASCULAR DISEASE; HUMAN; INTRACELLULAR SIGNALING; NECROPTOSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROSURGEON; NEUROSURGICAL DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTON TRANSPORT; REVIEW; TRAUMATIC BRAIN INJURY; ANTAGONISTS AND INHIBITORS; BRAIN INJURIES; CELL DEATH; CEREBROVASCULAR DISORDERS; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; BRAIN INJURIES; CELL DEATH; CEREBROVASCULAR DISORDERS; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; HUMANS; HYDROXYCHOLESTEROLS; NECROSIS; NEUROPROTECTIVE AGENTS; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84927772234     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20144310     Document Type: Review

References (79)

1. Healy E, Dempsey M, Lally C, Ryan MP. Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line. Kidney Int 1998; 54: 1955-1966, doi: 10.1046/j.1523-1755.1998.00202.x.
2. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014; 15: 135-147, doi: 10.1038/nrm3737.
3. Vanlangenakker N, Vanden Berghe T, Vandenabeele P. Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 2012; 19: 75-86, doi: 10.1038/cdd.2011.164.
4. Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013; 38: 209-223, doi: 10.1016/j.immuni.2013.02.003.
5. Degterev A, Hitomi J, Germscheid M, Ch’en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008; 4: 313-321, doi: 10.1038/nchembio.83.
6. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 1: 489-495, doi: 10.1038/82732.
7. Feng S, Yang Y, Mei Y, Ma L, Zhu DE, Hoti N, et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 2007; 19: 2056-2067, doi: 10.1016/j.cellsig.2007.05.016.
8. Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, Vucic D, et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 2014; 343: 1357-1360, doi: 10.1126/science.1249361.
9. Saeed WK, Jun DW. Necroptosis: an emerging type of cell death in liver diseases. World J Gastroenterol 2014; 20: 12526-12532, doi: 10.3748/wjg.v20.i35.12526.
10. Zhou W, Yuan J. Necroptosis in health and diseases. Semin Cell Dev Biol 2014; 35: 14-23, doi: 10.1016/j.semcdb.2014.07. 013.
11. Jouan-Lanhouet S, Riquet F, Duprez L, Vanden Berghe T, Takahashi N, Vandenabeele P. Necroptosis, in vivo detection in experimental disease models. Semin Cell Dev Biol 2014; 35: 2-13, doi: 10.1016/j.semcdb.2014.08.010.
12. Linkermann A, Hackl MJ, Kunzendorf U, Walczak H, Krautwald S, Jevnikar AM. Necroptosis in immunity and ischemia-reperfusion injury. Am J Transplant 2013; 13: 2797-2804, doi: 10.1111/ajt.12448.
13. Challa S, Chan FK. Going up in flames: necrotic cell injury and inflammatory diseases. Cell Mol Life Sci 2010; 67: 3241-3253, doi: 10.1007/s00018-010-0413-8.
14. Dmitriev YV, Minasian SM, Demchenko EA, Galagudza MM. Study of cardioprotective effects of necroptosis inhibitors on isolated rat heart subjected to global ischemia-reperfusion. Bull Exp Biol Med 2013; 155: 245-248, doi: 10.1007/s10517-013-2124-2.
15. Koshinuma S, Miyamae M, Kaneda K, Kotani J, Figueredo VM. Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemiareperfusion injury. J Anesth 2014; 28: 235-241, doi: 10.1007/ s00540-013-1716-3.
16. Li Y, Yang X, Ma C, Qiao J, Zhang C. Necroptosis contributes to the NMDA-induced excitotoxicity in rat’s cultured cortical neurons. Neurosci Lett 2008; 447: 120-123, doi: 10.1016/ j.neulet.2008.08.037.
17. Yamanaka K, Saito Y, Yamamori T, Urano Y, Noguchi N. 24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis. J Biol Chem 2011; 286: 24666-24673, doi: 10.1074/jbc.M111.236273.
18. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1: 112-119, doi: 10.1038/nchembio711.
19. King MD, Whitaker-Lea WA, Campbell JM, Alleyne CH Jr, Dhandapani KM. Necrostatin-1 reduces neurovascular injury after intracerebral hemorrhage. Int J Cell Biol 2014; 2014: 495817, doi: 10.1155/2014/495817.
20. Zhong CQ, Li Y, Yang D, Zhang N, Xu X, Wu Y, et al. Quantitative phosphoproteomic analysis of RIP3-dependent protein phosphorylation in the course of TNF-induced necroptosis. Proteomics 2014; 14: 713-724, doi: 10.1002/pmic.2013 00326.
21. Wilson NS, Dixit V, Ashkenazi A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol 2009; 10: 348-355, doi: 10.1038/ ni.1714.
22. Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 2000; 288: 2351-2354, doi: 10.1126/science.288.5475.2351.
23. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998; 17: 2215-2223, doi: 10.1093/emboj/ 17.8.2215.
24. Vanlangenakker N, Vanden Berghe T, Bogaert P, Laukens B, Zobel K, Deshayes K, et al. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ 2011; 18: 656-665, doi: 10.1038/cdd.2010.138.
25. Morioka S, Broglie P, Omori E, Ikeda Y, Takaesu G, Matsumoto K, et al. TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation. J Cell Biol 2014; 204: 607-623, doi: 10.1083/jcb.201305070.
26. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008; 135: 1311-1323, doi: 10.1016/j.cell.2008.10.044.
27. Christofferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 2010; 22: 263-268, doi: 10.1016/j.ceb.2009.12.003.
28. He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137: 1100-1111, doi: 10.1016/j.cell.2009.05.021.
29. Li L, Chen W, Liang Y, Ma H, Li W, Zhou Z, et al. The Gbetagamma-Src signaling pathway regulates TNFinduced necroptosis via control of necrosome translocation. Cell Res 2014; 24: 417-432, doi: 10.1038/cr.2014.17.
30. Christofferson DE, Li Y, Yuan J. Control of life-or-death decisions by RIP1 kinase. Annu Rev Physiol 2014; 76: 129-150, doi: 10.1146/annurev-physiol-021113-170259.
31. Shulga N, Pastorino JG. GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis. J Cell Sci 2012; 125: 2995-3003, doi: 10.1242/ jcs.103093.
32. Upton JW, Kaiser WJ, Mocarski ES. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 2010; 7: 302-313, doi: 10.1016/j.chom.2010.03.006.
33. Narayan N, Lee IH, Borenstein R, Sun J, Wong R, Tong G, et al. The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature 2012; 492: 199-204, doi: 10.1038/nature11700.
34. Lim SY, Davidson SM, Mocanu MM, Yellon DM, Smith CC. The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore. Cardiovasc Drugs Ther 2007; 21: 467-469, doi: 10.1007/s10557-007-6067-6.
35. Moriwaki K, Chan FK. RIP3: a molecular switch for necrosis and inflammation. Genes Dev 2013; 27: 1640-1649, doi: 10.1101/gad.223321.113.
36. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstreamof RIP3 kinase. Cell 2012; 148: 213-227, doi: 10.1016/j.cell.2011.11.031.
37. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S, et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013; 39: 443-453, doi: 10.1016/j.immuni.2013.06.018.
38. Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 2013; 288: 31268-31279, doi: 10.1074/jbc.M113.462341.
39. Kim SJ, Li J. Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia. Cell Death Dis 2013; 4: e716, doi: 10.1038/cddis.2013.238.
40. Schworer SA, Smirnova II, Kurbatova I, Bagina U, Churova M, Fowler T, et al. Toll-like receptor-mediated down-regulation of the deubiquitinase cylindromatosis (CYLD) protects macrophages from necroptosis in wild-derived mice. J Biol Chem 2014; 289: 14422-14433, doi: 10.1074/jbc.M114.547547.
41. Lin Y, Choksi S, Shen HM, Yang QF, Hur GM, Kim YS, et al. Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 2004; 279: 10822-10828, doi: 10.1074/jbc.M313141200.
42. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005; 120: 649-661, doi: 10.1016/j.cell. 2004.12.041.
43. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185: 1481-1486, doi: 10.1084/jem.185.8.1481.
44. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, et al. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell 2002; 13: 978-988, doi: 10.1091/mbc.01-05-0272.
45. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99-163, doi: 10.1152/physrev.00013.2006.
46. Boujrad H, Gubkina O, Robert N, Krantic S, Susin SA. AIFmediated programmed necrosis: a highly regulated way to die. Cell Cycle 2007; 6: 2612-2619, doi: 10.4161/cc.6.21.4842.
47. Xu Y, Huang S, Liu ZG, Han J. Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem 2006; 281: 8788-8795, doi: 10.1074/jbc.M508135200.
48. Devalaraja-Narashimha K, Diener AM, Padanilam BJ. Cyclophilin D gene ablation protects mice from ischemic renal injury. Am J Physiol Renal Physiol 2009; 297: F749-F759, doi: 10.1152/ajprenal.00239.2009.
49. Zhivotovsky B, Galluzzi L, Kepp O, Kroemer G. Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery. Cell Death Differ 2009; 16: 1419-1425, doi: 10.1038/cdd.2009.118.
50. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J, et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A 2005; 102: 12005-12010, doi: 10.1073/pnas.0505294102.
51. Huai J, Vogtle FN, Jockel L, Li Y, Kiefer T, Ricci JE, et al. TNFalpha-induced lysosomal membrane permeability is downstream of MOMP and triggered by caspase-mediated NDUFS1 cleavage and ROS formation. J Cell Sci 2013; 126: 4015-4025, doi: 10.1242/jcs.129999.
52. Vanden Berghe T, Vanlangenakker N, Parthoens E, Deckers W, Devos M, Festjens N, et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 2010; 17: 922-930, doi: 10.1038/ cdd.2009.184.
53. Suffys P, Beyaert R, De Valck D, Vanhaesebroeck B, Van Roy F, Fiers W. Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. Eur J Biochem 1991; 195: 465-475, doi: 10.1111/j.1432-1033.1991.tb15727.x.
54. Kim WH, Choi CH, Kang SK, Kwon CH, Kim YK. Ceramide induces non-apoptotic cell death in human glioma cells. Neurochem Res 2005; 30: 969-979, doi: 10.1007/s11064-005-6223-y.
55. Thon L, Mohlig H, Mathieu S, Lange A, Bulanova E, Winoto-Morbach S, et al. Ceramide mediates caspase-independent programmed cell death. FASEB J 2005; 19: 1945-1956, doi: 10.1096/fj.05-3726com.
56. Ma J, You C, Ma L, Huang S. Is decompressive craniectomy useless in severe traumatic brain injury? Crit Care 2011; 15: 193, doi: 10.1186/cc10358.
57. Algattas H, Huang JH. Traumatic Brain Injury pathophysiology and treatments: early, intermediate, and late phases post-injury. Int J Mol Sci 2014; 15: 309-341, doi: 10.3390/ ijms15010309.
58. You Z, Savitz SI, Yang J, Degterev A, Yuan J, Cuny GD, et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact inmice. J Cereb Blood Flow Metab 2008; 28: 1564-1573, doi: 10.1038/jcbfm.2008.44.
59. Erlich S, Alexandrovich A, Shohami E, Pinkas-Kramarski R. Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 2007; 26: 86-93, doi: 10.1016/ j.nbd.2006.12.003.
60. Chen S, Atkins CM, Liu CL, Alonso OF, Dietrich WD, Hu BR. Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury. J Cereb Blood Flow Metab 2007; 27: 939-949.
61. Park J, Zhang J, Qiu J, Zhu X, Degterev A, Lo EH, et al. Combination therapy targeting Akt and mammalian target of rapamycin improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 2012; 32: 330-340, doi: 10.1038/jcbfm.2011.131.
62. Liu Q, Qiu J, Liang M, Golinski J, van Leyen K, Jung JE, et al. Akt and mTOR mediate programmed necrosis in neurons. Cell Death Dis 2014; 5: e1084, doi: 10.1038/cddis.2014.69.
63. Lwin Z, MacFadden D, Al-Zahrani A, Atenafu E, Miller BA, Sahgal A, et al. Glioblastoma management in the temozolomide era: have we improved outcome? J Neurooncol 2013; 115: 303-310, doi: 10.1007/s11060-013-1230-3.
64. Han W, Xie J, Li L, Liu Z, Hu X. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis 2009; 14: 674-686, doi: 10.1007/s10495-009-0334-x.
65. Huang C, Luo Y, Zhao J, Yang F, Zhao H, Fan W, et al. Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS One 2013; 8: e66326, doi: 10.1371/journal.-pone.0066326.
66. Nomura M, Ueno A, Saga K, Fukuzawa M, Kaneda Y. Accumulation of cytosolic calcium induces necroptotic cell death in human neuroblastoma. Cancer Res 2014; 74: 1056-1066, doi: 10.1158/0008-5472.CAN-13-1283.
67. Coupienne I, Bontems S, Dewaele M, Rubio N, Habraken Y, Fulda S, et al. NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy. Biochem Pharmacol 2011; 81: 606-616, doi: 10.1016/j.bcp.2010.12.015.
68. Pasupuleti N, Leon L, Carraway KL III, Gorin F. 5-Benzylglycinyl-amiloride kills proliferating and nonproliferating malignant glioma cells through caspase-independent necroptosismediated by apoptosis-inducing factor. J Pharmacol Exp Ther 2013; 344: 600-615, doi: 10.1124/jpet.112.200519.
69. Liu X, Chhipa RR, Nakano I, Dasgupta B. The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent. Mol Cancer Ther 2014; 13: 596-605, doi: 10.1158/1535-7163.MCT-13-0579.
70. Broessner G, Beer R, Lackner P, Helbok R, Fischer M, Pfausler B, et al. Prophylactic, endovascularly based, longterm normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke 2009; 40: e657-e665, doi: 10.1161/STROKEAHA.109.557652.
71. Mathers CD, Boerma T, Ma FD. Global and regional causes of death. Br Med Bull 2009; 92: 7-32, doi: 10.1093/bmb/ ldp028.
72. Xu X, Chua KW, Chua CC, Liu CF, Hamdy RC, Chua BH. Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Res 2010; 1355: 189-194, doi: 10.1016/j.brainres.2010.07.080.
73. Wang JY, Xia Q, Chu KT, Pan J, Sun LN, Zeng B, et al. Severe global cerebral ischemia-induced programmed necrosis of hippocampal CA1 neurons in rat is prevented by 3-methyladenine: a widely used inhibitor of autophagy. J Neuropathol Exp Neurol 2011; 70: 314-322, doi: 10.1097/ NEN.0b013e31821352bd.
74. Gong Y, Hua Y, Keep RF, Hoff JT, Xi G. Intracerebral hemorrhage: effects of aging on brain edema and neurological deficits. Stroke 2004; 35: 2571-2575, doi: 10.1161/ 01.STR.0000145485.67827.d0.
75. Chang P, Dong W, Zhang M, Wang Z, Wang Y, Wang T, et al. Anti-necroptosis chemical necrostatin-1 can also suppress apoptotic and autophagic pathway to exert neuroprotective effect in mice intracerebral hemorrhage model. J Mol Neurosci 2014; 52: 242-249, doi: 10.1007/s12031-013-0132-3.
76. Bjorkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 2004; 24: 806-815, doi: 10.1161/01.ATV.0000120374.59826.1b.
77. Bjorkhem I, Andersson U, Ellis E, Alvelius G, Ellegard L, Diczfalusy U, et al. From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J Biol Chem 2001; 276: 37004-37010, doi: 10.1074/jbc.M103828200.
78. Yamanaka K, Urano Y, Takabe W, Saito Y, Noguchi N. Induction of apoptosis and necroptosis by 24(S)-hydroxycholesterol is dependent on activity of acyl-CoA:cholesterol acyltransferase 1. Cell Death Dis 2014; 5: e990, doi: 10.1038/cddis.2013.524.
79. O’Donnell MA, Perez-Jimenez E, Oberst A, Ng A, Massoumi R, Xavier R, et al. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 2011; 13: 1437-1442, doi: 10.1038/ncb2362.